Cargando…
Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability
Ischemic stroke remains a heavy burden for industrialized countries. The only causal therapy is the recanalization of occluded vessels via thrombolysis, which due to a narrow time window still can be offered only to a minority of patients. Since the majority of patients continues to exhibit neurolog...
Autores principales: | Doeppner, Thorsten R., Hermann, Dirk M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212679/ https://www.ncbi.nlm.nih.gov/pubmed/25400548 http://dx.doi.org/10.3389/fncel.2014.00357 |
Ejemplares similares
-
Editorial: Stem cells and progenitor cells in ischemic stroke—fashion or future?
por: Doeppner, Thorsten R., et al.
Publicado: (2015) -
Stem cell therapies in preclinical models of stroke associated with aging
por: Popa-Wagner, Aurel, et al.
Publicado: (2014) -
Correlates of Post-Stroke Brain Plasticity, Relationship to Pathophysiological Settings and Implications for Human Proof-of-Concept Studies
por: Sanchez-Mendoza, Eduardo H., et al.
Publicado: (2016) -
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
por: Doeppner, Thorsten R, et al.
Publicado: (2010) -
Effects of neural progenitor cells on post-stroke neurological impairment—a detailed and comprehensive analysis of behavioral tests
por: Doeppner, Thorsten R., et al.
Publicado: (2014)